Tuszynski M - Search Results

1

Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.

Bishop KM, Hofer EK, Mehta A, Ramirez A, Sun L, Tuszynski M, Bartus RT. Bishop KM, et al. Among authors: tuszynski m. Exp Neurol. 2008 Jun;211(2):574-84. doi: 10.1016/j.expneurol.2008.03.004. Epub 2008 Mar 19. Exp Neurol. 2008. PMID: 18439998 Free PMC article.

2

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain.

Tuszynski MH, Sang H, Yoshida K, Gage FH. Tuszynski MH, et al. Ann Neurol. 1991 Nov;30(5):625-36. doi: 10.1002/ana.410300502. Ann Neurol. 1991. PMID: 1763889

3

Regional differences in responsiveness of adult CNS axons to grafts of cells expressing human neurotrophin 3.

Senut MC, Tuszynski MH, Raymon HK, Suhr ST, Liou NH, Jones KR, Reichardt LF, Gage FH. Senut MC, et al. Among authors: tuszynski mh. Exp Neurol. 1995 Sep;135(1):36-55. doi: 10.1006/exnr.1995.1064. Exp Neurol. 1995. PMID: 7556552

4

Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord.

Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH. Tuszynski MH, et al. Exp Neurol. 1994 Mar;126(1):1-14. doi: 10.1006/exnr.1994.1037. Exp Neurol. 1994. PMID: 8157119

5

Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury.

Tuszynski MH, Gabriel K, Gage FH, Suhr S, Meyer S, Rosetti A. Tuszynski MH, et al. Exp Neurol. 1996 Jan;137(1):157-73. doi: 10.1006/exnr.1996.0016. Exp Neurol. 1996. PMID: 8566208

6

Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor.

Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Day-Lollini PA, Stewart GR, Tuszynski MH, Gage FH, Thal LJ. Winkler J, et al. Among authors: tuszynski mh. Ann Neurol. 1997 Jan;41(1):82-93. doi: 10.1002/ana.410410114. Ann Neurol. 1997. PMID: 9005869

7

Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.

Grill RJ, Blesch A, Tuszynski MH. Grill RJ, et al. Among authors: tuszynski mh. Exp Neurol. 1997 Dec;148(2):444-52. doi: 10.1006/exnr.1997.6704. Exp Neurol. 1997. PMID: 9417824

8

Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition.

Tuszynski MH, Smith DE, Roberts J, McKay H, Mufson E. Tuszynski MH, et al. Exp Neurol. 1998 Dec;154(2):573-82. doi: 10.1006/exnr.1998.6956. Exp Neurol. 1998. PMID: 9878192

9

Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration.

Weidner N, Grill RJ, Tuszynski MH. Weidner N, et al. Among authors: tuszynski mh. Exp Neurol. 1999 Nov;160(1):40-50. doi: 10.1006/exnr.1999.7200. Exp Neurol. 1999. PMID: 10630189

10

Intraparenchymal NGF infusions rescue degenerating cholinergic neurons.

Tuszynski MH. Tuszynski MH. Cell Transplant. 2000 Sep-Oct;9(5):629-36. doi: 10.1177/096368970000900508. Cell Transplant. 2000. PMID: 11144960 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters